On this page
Bloom syndrome
This rare genetic disorder leads to slowed growth from before birth, sun-sensitive skin changes, and a weakened immune system. Individuals with Bloom syndrome face a significantly increased risk of developing many types of cancer, often at an early age.
Available at Jeen Health
Clinical tests that include this
Overview
Bloom syndrome is a very rare genetic condition, also known as Bloom-Torre-Machacek syndrome, that affects multiple body systems. It is inherited in an autosomal recessive pattern, meaning both parents must carry a change in the same specific gene for their child to be affected. A key characteristic is growth deficiency, starting before birth and continuing throughout life, resulting in short stature. Affected individuals often have a distinctive facial appearance, with prominent noses and sun-sensitive skin rashes, especially on the face [PMID:20301322].
People with Bloom syndrome have a significantly increased risk of developing various types of cancer, usually at a younger age than is typical in the general population. This risk is a major concern and requires careful monitoring. Additionally, a weakened immune system often makes individuals with Bloom syndrome more susceptible to infections. The condition is particularly rare in the general population, though it is found more frequently within individuals of Ashkenazi Jewish heritage.
Symptoms & clinical features
The symptoms of Bloom syndrome are varied and can affect several parts of the body. Growth retardation is a hallmark feature, beginning before birth, leading to low birth weight and short stature that persists throughout life. Affected individuals typically have a slender build and often have a distinctive facial appearance [PMID:20301322].
Skin features are also common, particularly a red, butterfly-shaped rash that appears on the face after sun exposure. Other sun-sensitive skin changes may occur, and individuals with Bloom syndrome are prone to developing telangiectasias (small, dilated blood vessels) on the face. Immune system deficiencies are also frequently observed, leading to recurrent infections, especially respiratory and ear infections. Other potential health issues include endocrine problems like diabetes, fertility issues, and intellectual disability in a small proportion of cases.
Video: Is cancer in your genes?
Affected organs
Bloom syndrome affects several organ systems due to its impact on DNA repair mechanisms. The skeletal system is notably affected by severe growth retardation, resulting in uniformly short stature. The skin is highly sensitive to ultraviolet (UV) light, leading to characteristic rashes, particularly on the face, and increased risk of skin cancers.
The immune system is typically compromised, making individuals more vulnerable to infections. Various internal organs can also develop cancer, including those in the gastrointestinal tract, blood-forming organs (leading to leukaemia or lymphoma), and solid tumours in different tissues. Endocrine glands, particularly the pancreas, can be affected, increasing the risk of diabetes mellitus.
Risks & severity
Individuals with Bloom syndrome face a significantly elevated lifetime risk of developing cancer. This risk extends to a wide range of cancer types, including leukaemias, lymphomas, and various solid tumours, often emerging much earlier in life than in the general population [PMID:20301322]. This severe cancer predisposition is a defining characteristic of the condition and contributes significantly to reduced life expectancy.
Severity of symptoms can vary among affected individuals, but chronic growth deficiency and sun sensitivity are almost always present. The immune system dysfunction can range from mild to severe, influencing the frequency and seriousness of infections. Regular medical surveillance is crucial to manage the various health challenges associated with Bloom syndrome.
Genetic causes
Bloom syndrome is caused by pathogenic variants in the BLM gene. This gene provides instructions for making a protein called a RecQ helicase, which plays a critical role in maintaining the integrity of our DNA. The BLM protein is essential for processes like DNA synthesis, where cells duplicate their genetic material, and for repairing DNA damage. It functions by unwinding the DNA helix, a process fundamental to precise cellular operations.
When there is a pathogenic variant in the BLM gene, the BLM protein does not function correctly or is not produced at all. This leads to instability in the genome, meaning the DNA within cells is more prone to damage and errors. This increased genomic instability is thought to be the underlying reason for the characteristic features of Bloom syndrome, including the profound growth deficiency, immune system problems, and the significantly elevated risk of developing cancer.
- BLM BLM RecQ like helicaseThe BLM gene encodes a RecQ helicase enzyme vital for maintaining genomic stability through its role in DNA replication and repair processes.
Inheritance pattern
Bloom syndrome is inherited in an autosomal recessive pattern. This means that an individual must inherit two copies of the altered BLM gene - one from each parent - to have the condition. Typically, carriers of one altered BLM gene do not show symptoms of Bloom syndrome themselves, as they have one working copy of the gene.
If both parents are carriers of a pathogenic variant in the BLM gene, there is a one in four (25%) chance with each pregnancy that their child will inherit two altered copies and develop Bloom syndrome. There is a two in four (50%) chance that their child will be a carrier, and a one in four (25%) chance that their child will inherit two working copies of the gene and neither have the condition nor be a carrier.
When both parents are carriers, each child has a 25% chance of being affected, 50% of being a carrier, and 25% of being unaffected.
Diagnosis & testing
A diagnosis of Bloom syndrome is primarily based on characteristic clinical signs and symptoms, followed by confirmation through genetic testing. Key features that might suggest the condition include severe pre- and postnatal growth retardation, sun-sensitive facial rashes, and a history of recurrent infections or early-onset cancers. Laboratory tests showing increased chromosomal breakage in cells can also support a diagnosis [PMID:20301322].
Confirmation of Bloom syndrome typically involves genetic testing to identify pathogenic variants in the BLM gene. In the UK, genetic testing for suspected cases can be accessed through the NHS Genomic Medicine Service (GMS) via an appropriate clinical referral, for example, from a paediatrician or clinical geneticist. This testing routes through specific R-codes, ensuring comprehensive and appropriate genetic analysis.
Management & lifestyle
While there is no cure for Bloom syndrome, management focuses on addressing specific symptoms and vigilant screening for cancer. Regular medical appointments with a team of specialists, including paediatricians, oncologists, dermatologists, and immunologists, are crucial. Given the high cancer risk, individuals with Bloom syndrome undergo frequent surveillance for various cancer types, which may involve regular imaging, blood tests, and other screening procedures tailored to their specific risks.
Managing sun sensitivity involves strict sun avoidance, protective clothing, and high-factor sunscreen. Recurrent infections are managed with appropriate antibiotics and, in some cases, immunoglobulin replacement therapy to support the immune system. Lifestyle considerations include avoiding known carcinogens and maintaining a healthy diet. Genetic counselling is highly recommended for affected individuals and their families to understand the inheritance pattern and reproductive risks.
UK care pathway
In the UK, individuals suspected of having genetic conditions like Bloom syndrome would typically be referred to a Clinical Genetics service. This pathway ensures access to specialist genetic assessments, diagnostic testing via the NHS Genomic Medicine Service (GMS), and relevant genetic counselling. Genetic testing for Bloom syndrome falls under specific GMS R-codes, enabling targeted analysis of the BLM gene.
Following a diagnosis, a multidisciplinary team approach would often be coordinated through specialist NHS centres. Genetic counsellors play a vital role in explaining the condition, its inheritance, and implications for family members, as well as helping individuals and families navigate the care pathway and access support services.
Frequently asked questions
What is the life expectancy for someone with Bloom syndrome?
Life expectancy for individuals with Bloom syndrome is reduced primarily due to the significantly increased risk of developing cancer, often at a young age. With careful surveillance and management, individuals can live into adulthood, but the average lifespan is typically shorter than that of the general population.
Are there any specific treatments for the growth problems in Bloom syndrome?
Currently, there are no specific treatments that can fully correct the profound growth deficiency seen in Bloom syndrome. Management focuses on overall health, nutrition, and managing other symptoms. Growth hormone therapy has been explored in some cases, but its effectiveness for Bloom syndrome is not well established.
Can people with Bloom syndrome have children?
Some individuals with Bloom syndrome may experience fertility challenges. Genetic counselling is important for those considering family planning to discuss reproductive options and implications.
Is Bloom syndrome more common in certain ethnic groups?
Bloom syndrome is considered a pan-ethnic condition, meaning it can occur in any population. However, it is observed with a higher frequency within populations of Ashkenazi Jewish heritage, where a specific founder pathogenic variant in the BLM gene is more common.
What kind of cancer screening is recommended for Bloom syndrome?
Individuals with Bloom syndrome typically follow a rigorous cancer surveillance plan tailored to their specific risks. This often includes regular physical examinations, blood tests, imaging studies (like ultrasound or MRI), and sometimes endoscopy, to detect cancers as early as possible. The exact screening schedule is determined by specialist doctors.
References
- Hafsi W, Badri T, Rice AS. Bloom Syndrome. 2023. PMID: 28846287
- Arora H, Chacon AH, Choudhary S. Bloom syndrome. International journal of dermatology. 2014. PMID: 24602044
- Jeggo P, Van Houten B. Editors' Note. DNA repair. 2026. PMID: 42386453
- German J. Bloom's syndrome. Dermatologic clinics. 1995. PMID: 7712653
- Tsukada K, Jones SE, Bannister J. BLM and BRCA1-BARD1 coordinate complementary mechanisms of joint DNA molecule resolution. Molecular cell. 2024. PMID: 38266639
- Lu L, Jin W, Wang LL. RECQ DNA Helicases and Osteosarcoma. Advances in experimental medicine and biology. 2020. PMID: 32767233
- Rauh JL, Soukup SW. Bloom's syndrome. American journal of diseases of children (1960). 1968. PMID: 4177243
- Ababou M. Bloom syndrome and the underlying causes of genetic instability. Molecular genetics and metabolism. 2021. PMID: 33736941